Literature DB >> 25549344

Lymphoscintigraphy for the assessment of autologous stem cell implantation in chronic lymphedema.

Yamilé Peña Quián1, Porfirio Hernández Ramirez, Juan F Batista Cuellar, Alejandro Perera Pintado, Marco A Coca Pérez.   

Abstract

Lymphoscintigraphy is the criterion standard technique for the diagnosis of lymphedema. The authors present the images acquired before and 6 months after implantation of autologous stem cells in 2 patients with chronic lymphedema of the lower limbs. The stem cells implantations were carried out by multiple superficial and deep injections in the trajectory of the lymphatic vessels and also in the inguinal region. A volume of 0.75 to 1.00 mL of cell suspension (1.0-2.2 × 10(9) stem cells) was administered in each injection site. The anatomy and function of the lymphatic system were evaluated.

Entities:  

Mesh:

Year:  2015        PMID: 25549344     DOI: 10.1097/RLU.0000000000000688

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

1.  Use of bone marrow-derived cells for regenerative medicine in Cuba.

Authors:  P Hernández
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

2.  Potential Applications of Using 68Ga-Evans Blue PET/CT in the Evaluation of Lymphatic Disorder: Preliminary Observations.

Authors:  Wei Zhang; Peilin Wu; Fang Li; Guansheng Tong; Xiaoyuan Chen; Zhaohui Zhu
Journal:  Clin Nucl Med       Date:  2016-04       Impact factor: 7.794

Review 3.  Therapeutic Potential of Mesenchymal Stem Cells for Postmastectomy Lymphedema: A Literature Review.

Authors:  Kuo Chen; Mikhail Y Sinelnikov; Igor V Reshetov; Petr Timashev; Yuanting Gu; Lan Mu; Pengwei Lu; Yuanyuan Zhang
Journal:  Clin Transl Sci       Date:  2020-08-30       Impact factor: 4.689

4.  The relationship between the drainage function of inguinal lymph nodes and unilateral pelvic cancer-related lymphedema: A retrospective analysis.

Authors:  Guozhu Hou; Yuwei Zhang; Libo Chen; Fang Li; Hongli Jing
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.